Study supports Roche's disputed blockbuster flu drug Tamiflu

Study supports Roche's disputed blockbuster flu drug Tamiflu

LONDON Jan 30 (Reuters) – A major analysis of one of the world's most fiercely disputed medicines, Roche's Tamiflu, has found it cuts flu symptoms by a day and can help some patients avoid hospital treatment and complications. But the drug can also

6
Like
Save

Comments

Write a comment

*